These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4054570)

  • 21. [Aspects of perfluoro-organic hemo-protection].
    Shevchenko IuL; Skorik VI; Sudus AV
    Anesteziol Reanimatol; 1995; (6):17-9. PubMed ID: 8713414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A perfluorochemical emulsion as an oxygen carrier.
    Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A perfluorocarbon emulsion inhibits neutrophil activation].
    Obraztsov VV; Shekhtman DG; Sklifas AN; Gapeev AB; Safronova VG; Chemeris NK; Sukharev SA; Sadovnikov VB
    Dokl Akad Nauk; 1995 Jun; 342(6):819-22. PubMed ID: 7580965
    [No Abstract]   [Full Text] [Related]  

  • 24. Biocompatibility studies with perfluorochemical oxygen carriers.
    Lowe KC; Armstrong FH
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):993-9. PubMed ID: 1391544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of artificial oxygen carriers.
    Spahn DR
    Adv Drug Deliv Rev; 2000 Feb; 40(3):143-51. PubMed ID: 10837786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against hyperacute rejection in discordant lung xenografts.
    Sugawara Y; Matsuura Y; Sueda T; Wada S; Ochikubo H; Kajihara H
    Transplant Proc; 1998 Nov; 30(7):3826-30. PubMed ID: 9838675
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphological analysis of the rat organs after massive blood substitution with perfluorotributylamine emulsion].
    Golubev AM; Vasil'ev AE; Shibaev NV; Maevskiĭ EI; Islamov BI
    Arkh Patol; 1982; 44(11):55-60. PubMed ID: 7159239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leuko- and thrombocytopenic reactions of the body to the intravenous administration of emulsions of perfluoro-organic compounds].
    Sedova LA; Berkos MV; Piatovskaia NN
    Gematol Transfuziol; 1988 Nov; 33(11):45-8. PubMed ID: 3234728
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of a novel perfluorocarbon emulsion on neutrophil chemiluminescence in human whole blood in vitro.
    Edwards CM; Lowe KC; Röhlke W; Geister U; Reuter P; Meinert H
    Artif Cells Blood Substit Immobil Biotechnol; 1997 May; 25(3):255-60. PubMed ID: 9167840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in lactate dehydrogenase activity and lactic and pyruvic acid concentration in the blood and tissues of animals following intravenous administration of perfluorotributylamine emulsions].
    Afonin NI; Doronina NN; Smelova OS; Ivanova NL; Putiatina TK
    Vopr Med Khim; 1980; 26(2):185-7. PubMed ID: 7456348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
    Ravis WR; Hoke JF; Parsons DL
    Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Elimination of perfluoro-organic compounds from rat organs].
    Aprosin IuD; Sidliarov DP; Rybolovlev IuR; Shushina LV; Afonin NI
    Gematol Transfuziol; 1983 Apr; 28(4):44-9. PubMed ID: 6852513
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820
    [No Abstract]   [Full Text] [Related]  

  • 34. PFC as blood substitutes--an overview.
    Geyer RP
    Prog Clin Biol Res; 1983; 122():157-68. PubMed ID: 6878357
    [No Abstract]   [Full Text] [Related]  

  • 35. Physiological effects of perfluorocarbon blood substitutes.
    Lowe KC; Bollands AD
    Med Lab Sci; 1985 Oct; 42(4):367-75. PubMed ID: 3908874
    [No Abstract]   [Full Text] [Related]  

  • 36. [A new model describing the isolation of fluorocarbons from an organism: dissolution of fluorocarbons in the lipid components of blood].
    Obraztsov VV; Kabal'noĭ AS; Sklifas AN; Makarov KN
    Biofizika; 1992; 37(2):379-83. PubMed ID: 7578329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorocarbon emulsions as a synthetic blood substitute: effects on microvascular hemodynamics in the rabbit omentum.
    Endrich B; Newman MM; Greenburg AG; Intaglietta M
    J Surg Res; 1980 Dec; 29(6):516-26. PubMed ID: 7431906
    [No Abstract]   [Full Text] [Related]  

  • 38. Disposition of phenytoin in rats treated with Fluosol-43, a perfluorochemical artificial blood substitute.
    Matsumoto J; Bianchine J; Thompson R; Sharp D; Andresen B; Ng K; Gerber N
    Proc West Pharmacol Soc; 1983; 26():403-7. PubMed ID: 6889371
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of perfluorodecalin and perfluorooctylbromide emulsions on peak contractile force and ATP levels in the guinea pig left atrium.
    Eyer CL; Olszanski AJ; Smith JR; Anderson AC; Irem SO
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):719-29. PubMed ID: 1810406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in intravascular fluid composition following blood replacement with perfluorocarbon emulsion in the rat.
    Lowe KC; McNaughton DC; Hardy RN
    Klin Wochenschr; 1985 Oct; 63(19):1028-34. PubMed ID: 4068605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.